January 25, 2021
Mitsubishi Tanabe Pharma has sealed a licensing and supply pact to obtain the US rights to commercialize Aquestive Therapeutics’ Exservan (riluzole), an oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosis (ALS), the two companies said. The...read more